Target intelligence / Profile preview

Long intergenic non-protein coding RNA 606 (LINC00606)

Target
LINC00606
Molecular classification
Long non-coding RNA, long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 606 (LINC00606) is a human long non-coding RNA (lncRNA), specifically a long intergenic non-coding RNA (lincRNA) that does not overlap protein-coding genes. LINC00606 is highly expressed in some tumor types, notably glioblastoma, where it drives cell proliferation and migration, and suppresses apoptosis. Functionally, it regulates gene networks through sponging microRNAs (e.g., miR-486-3p), modulating the expression of genes like TCF12, and interacting with the protein ATP11B to impact signaling pathways including PI3K/AKT. Its high expression is associated with poor prognosis in glioma, suggesting its utility as a biomarker. No approved drugs directly target LINC00606, and therapeutic targeting is an emerging research area rather than established clinical reality.

Other names
LINC00606Long intergenic non-protein coding RNA 606
02

Mechanism of action

Acts as a competing endogenous RNA ("molecular sponge") for microRNAs such as miR-486-3p, thereby regulating the expression of downstream genes (e.g., TCF12); Binds to proteins (e.g., ATP11B) and modulates the PI3K/AKT signaling pathway

03

Biological functions

Regulation of gene expression (transcriptional and post-transcriptional)Cell proliferationCell migrationApoptosis regulation
04

Disease associations

Cancer (with demonstrated roles especially in glioblastoma/glioma)
05

Safety considerations

None specifically reported. As a non-coding RNA, therapeutic targeting strategies and their safety are experimental; off-target effects or antisense/siRNA therapy risks are general concerns for lncRNA targeting.
06

Biomarkers

High LINC00606 expression can serve as a molecular biomarker correlated with poor prognosis in glioblastoma and possibly low-grade glioma

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 606 (LINC00606).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 606 (LINC00606).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call